Orthocell secures major US military hospital approval
Orthocell (ASX:OCC) secured approval to supply its Remplir nerve repair device to 221 DoD and Veterans Affairs hospitals.
Every story in this category, newest first.
Orthocell (ASX:OCC) secured approval to supply its Remplir nerve repair device to 221 DoD and Veterans Affairs hospitals.
Superannuation fund HESTA announced the appointment of Robbie Campo as its new CEO.
Legacy Minerals (ASX:LGM) entered into a binding agreement to divest its 100% interest in the Glenlogan Project.
AuMEGA Metals (ASX:AAM) announced the closure of a transformational CAD$30.1 million financing initiative.
Cobre (ASX:CBE) commenced a substantial 40,000-metre surface and underground drilling programme at its flagship Sierra Atacama Project.
The Australian Communications and Media Authority has slapped non-bank lender Latitude Group (ASX:LFS) with a $4 million fine.
Genetic Signatures (ASX:GSS) has signed a multi-year supply agreement with Denmark's Hvidovre Hospital.
Mesoblast (ASX:MSB) has acquired an exclusive worldwide licence for a chimeric antigen receptor technology platform.
As the US and Iran weigh a second round of peace talks in Pakistan, Miller Center Senior Fellow Mara Rudman breaks down the major sticking points. She discusses whether both nations can move past the disagreements to reach a way forward to reopen the Strait of Hormuz.
Accelerate Resources (ASX:AX8) commenced aircore drilling at its high-priority Fluffy prospect.
The Duratec Ertech joint venture has been awarded a $281 million contract by the Department of Defence.
Evolution Mining (ASX:EVN) has reported a suite of "promising" exploration results that signal growth potential for its core Australian operations.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy